RxDoctor Payments DataLook up a doctor →

Ann Shattuck, APRN

Gerontology · North Charleston, SCNPI 1417566936

Payments from drug & device makers

$14,736in general payments, 2019–2025

Across 621 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$1K
  • Novartis$1K
  • Merck$1K
  • AstraZeneca$918
  • E.r. Squibb & Sons, L.L.C.$894
  • Incyte Corporation$777
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,87094%
  • Education$8656%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb58$1,110
Novartis50$1,095
Merck47$1,063
AstraZeneca(2 entities)39$918
E.r. Squibb & Sons, L.L.C.43$894
Incyte Corporation21$777
Lilly USA, LLC23$572
Sanofi13$441
Amgen17$391
Daiichi Sankyo Inc.12$377
Jazz Pharmaceuticals Inc.17$372
Seagen Inc.16$370
Pfizer20$355
Gilead(2 entities)9$337
Johnson & Johnson13$332
Genentech USA, Inc.18$326
AbbVie16$303
Rigel Pharmaceuticals, Inc.7$289
Takeda Pharmaceuticals U.S.A., Inc.10$279
GSK13$265
AVEO Pharmaceuticals, Inc.6$250
Regeneron Healthcare Solutions, Inc.10$232
Pharmacyclics LLC, An Abbvie Company8$217
Novocure Inc.5$199
Astellas Pharma US Inc6$182
Stemline Therapeutics Inc.7$172
Taiho Oncology, Inc.7$158
Exelixis Inc.9$156
Eisai Inc.7$144
Epizyme, Inc.2$143
Sobi, Inc6$133
Array Biopharma Inc6$107
Beigene USA, Inc.5$102
Sanofi-aventis U.S. LLC1$100
Karyopharm Therapeutics Inc.4$97
Acrotech Biopharma Inc.5$95
Puma Biotechnology, Inc.5$95
Bayer4$91
Morphosys, US Inc.5$90
Boehringer Ingelheim3$79
Deciphera Pharmaceuticals Inc.3$79
Beone Medicines USA, Inc.4$77
ADC Therapeutics America, Inc.4$75
Tersera Therapeutics LLC4$68
Adaptive Biotechnologies Corporation3$64
Secura Bio, Inc.1$56
CTI Biopharma Corp.3$55
Ipsen Biopharmaceuticals, Inc3$54
Genmab U.S., Inc.2$52
Geron Corporation2$49
Mirati Therapeutics, Inc.2$45
Azurity Pharmaceuticals, Inc.2$43
Servier Pharmaceuticals LLC2$42
G1 Therapeutics, Inc.2$36
EMD Serono, Inc.2$35
Recordati_rare_diseases_inc.1$35
Accord Healthcare, Inc.1$33
Tolmar, Inc.1$29
Fennec Pharmaceuticals, Inc.1$24
Pharmacosmos Therapeutics Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,736 in reported general payments places this provider in the 95th percentile of 137 gerontology providers in South Carolina.

See all gerontology providers in South Carolina

Medicare billing

Part B allowed, 2024
$80,441
Medicare patients
342
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide34$564,488
XtandiEnzalutamide32$475,179
PomalystPomalidomide11$257,370
PromactaEltrombopag Olamine15$241,890
CalquenceAcalabrutinib Maleate15$228,051
TavalisseFostamatinib Disodium12$172,229
Everolimus20$147,294
EliquisApixaban37$34,816
Anastrozole133$3,176
Exemestane26$2,546
Dexamethasone36$1,413
Ondansetron OdtOndansetron44$830
Imatinib Mesylate11$813
Acyclovir53$740
Potassium Chloride25$455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$1,110$564,48834 claims
Astellas Pharma US IncXtandi$182$475,17932 claims
E.r. Squibb & Sons, L.L.C.Pomalyst$894$257,37011 claims
NovartisPromacta$1,095$241,89015 claims
AstraZenecaCalquence$918$228,05115 claims
Rigel Pharmaceuticals, Inc.Tavalisse$289$172,22912 claims
PfizerEliquis$355$34,81637 claims
Lilly USA, LLCOlanzapine$572$33120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 137 gerontology providers in South Carolina.

Other gerontology in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →